Pancreatic Cancer Research

Journal articleCase Rep Oncol2014

Long-term disease control of a pancreatic neuroendocrine tumor with lanreotide autogel(®): a case report.

Journal
Case Rep Oncol
Published
26 September 2014
Citations
2
License
cc by-nc

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract cc by-nc

The CLARINET study (ClinicalTrials.gov: NCT00353496) showed that somatostatin analogs are able to stabilize tumor growth in patients with intestinal and pancreatic neuroendocrine tumors (NETs). Here, we present a case of NET originating from the pancreatic tail that was treated with lanreotide Autogel(®). … Excerpt only: this text is the publisher’s. Read it in full at the source.